- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03388333
Biomarkers in Patients Undergoing Atrial Fibrillation Ablation
June 6, 2019 updated by: Prof. Dr. Christian Meyer, Universitätsklinikum Hamburg-Eppendorf
A Single-center Observational Study to Find Biomarkers for the Outcome of Catheter Ablation in Patients With Atrial Fibrillation
The investigators aim to find biomarkers to determine the success of pulmonary vein isolation for the treatment of atrial fibrillation.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The investigators perform an observational study in patients undergoing pulmonary vein ablation to treat atrial fibrillation.
Additionally, electrophysiological procedures not related to pulmonary vein isolation are also followed.
The aim of the study is finding biomarkers that are able to predict short-term outcome of the procedure.The primary endpoint is defined as reoccurrences of atrial fibrillation within the first three months after pulmonary vein isolation.
Study Type
Observational
Enrollment (Actual)
300
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Hamburg, Germany, 20246
- Department of Cardiology - Electrophysiology, University Heart Centre, University Hospital Hamburg-Eppendorf
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Patients with atrial fibrillation schedulded for pulmonary vein isolation
Description
Inclusion Criteria:
- patients with atrial fibrillation scheduled for pulmonary vein isolation with either radiofrequency of cryoballoon
- patients scheduled for an electrophysiological study without ablation
- patients with a catheter ablation at the cavotricuspid isthmus for the treatment of right atrial flutter
Exclusion Criteria:
- patients with concurrent pulmonary vein isolation and ablation of the cavotricuspid isthmus
- Acute myocardial infarction, coronary artery bypass graft surgery or open heart surgery within less than 3 months prior to inclusion
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Retrospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Atrial fibrillation ablation group
Patients undergoing catheter ablation for the treatment of atrial fibrillation.
|
|
Electrophysiological study group
Patients undergoing a diagnostic electrophysiological study without ablation.
|
|
Atrial flutter ablation group
Patients undergoing catheter ablation of right atrial flutter at the cavotricuspid isthmus.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of patients with short term reoccurrences of atrial fibrillation after ablation.
Time Frame: 3 months
|
Holter ECGs and ECGs after atrial fibrillation ablation
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in heart rate after pulmonary vein isolation
Time Frame: 3 days.
|
Heart rates are recorded at admission and release from the hospital.
|
3 days.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Christian Meyer, Prof. Dr., Germany Department of Cardiology - Electrophysiology, University Heart Centre
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2017
Primary Completion (Actual)
July 1, 2018
Study Completion (Actual)
April 1, 2019
Study Registration Dates
First Submitted
December 22, 2017
First Submitted That Met QC Criteria
December 22, 2017
First Posted (Actual)
January 2, 2018
Study Record Updates
Last Update Posted (Actual)
June 7, 2019
Last Update Submitted That Met QC Criteria
June 6, 2019
Last Verified
October 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- D4/17-06
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Atrial Fibrillation
-
Ablacon, Inc.CompletedArrhythmias, Cardiac | Atrial Fibrillation, Persistent | Persistent Atrial Fibrillation | Longstanding Persistent Atrial FibrillationGermany
-
Ablacon, Inc.RecruitingAtrial Fibrillation | Arrhythmias, Cardiac | Arrhythmia | Atrial Flutter | Atrial Fibrillation, Persistent | Atrial Tachycardia | Atrial Arrhythmia | Atrial Fibrillation Paroxysmal | Atrial Fibrillation, Paroxysmal or PersistentUnited States, Belgium, Netherlands, Czechia
-
Barts & The London NHS TrustAtriCure, Inc.Not yet recruitingAtrial Fibrillation, Persistent | Persistent Atrial Fibrillation | Atrial Arrhythmia | Atrium; FibrillationUnited Kingdom
-
AtriCure, Inc.Active, not recruitingPersistent Atrial Fibrillation | Atrial Fibrillation (AF) | Longstanding Persistent Atrial FibrillationUnited States
-
Maastricht University Medical CenterRWTH Aachen UniversityUnknownAtrial Fibrillation (Paroxysmal) | Atrial Fibrillation Recurrent | Atrial Fibrillation Common Gene VariantsNetherlands
-
Adagio MedicalRecruitingAtrial Fibrillation | Atrial Flutter | Paroxysmal Atrial Fibrillation | Persistent Atrial FibrillationNetherlands, Germany, Belgium
-
Vivek ReddyEnrolling by invitationAtrial Fibrillation and Flutter | Atrial Flutter Typical | Atrial Fibrillation, Paroxysmal or PersistentUnited States
-
Abbott Medical DevicesRecruitingAtrial Fibrillation | Paroxysmal Atrial Fibrillation | Persistent Atrial Fibrillation | Atrial ArrhythmiaUnited States, Spain, Belgium, Australia, Germany, Netherlands, France, Austria, Canada, Czechia, Italy, United Kingdom
-
Fundació Institut de Recerca de l'Hospital de la...RecruitingAtrial Arrhythmia | Atrial Fibrillation and Flutter | Atrial Fibrillation RecurrentSpain
-
St. George's Hospital, LondonRecruitingAtrial Fibrillation | Atrial Fibrillation, Persistent | Persistent Atrial Fibrillation | Atrial ArrhythmiaUnited Kingdom
Clinical Trials on Catheter Ablation
-
Charles University, Czech RepublicRecruitingAtrial FibrillationCzechia
-
Sheba Medical CenterMedtronicUnknownPremature Ventricular Contraction
-
Oxford University Hospitals NHS TrustRoyal Bournemouth and Christchurch Hospitals NHS Foundation TrustCompleted
-
Medtronic Cardiac Rhythm and Heart FailureCompletedAtrial Fibrillation | Paroxysmal Atrial FibrillationUnited States, France, Italy, Canada, Czechia
-
Cedars-Sinai Medical CenterBiosense Webster, Inc.Recruiting
-
Emory UniversityBoston Scientific CorporationCompleted
-
The Cleveland ClinicAtriCure, Inc.Not yet recruitingHeart Failure | Atrial FibrillationUnited States
-
Medtronic Bakken Research CenterTerminatedAtrial FibrillationNetherlands
-
China National Center for Cardiovascular DiseasesRecruitingConcomitant Hybrid Versus Catheter Ablation for Atrial Fibrillation With Hypertrophic CardiomyopathyAtrial Fibrillation | Cardiomyopathy, Hypertrophic | Radiofrequency AblationChina
-
Maastricht University Medical CenterCompleted